Interesting - a FREE COVID vaccination & get PAID!!!20 Oct 2020 23:38
Human challenge studies
Open Orphan PLC’s (LON:ORPH) hVIVO arm is set to start phase I of a human challenge trial for a nasal vaccine for coronavirus early next year.
It will quarantine young adults at a facility in north London to assess whether the drug provokes an immune response.
This type of study sees healthy participants are vaccinated then exposed to the virus to get infected.
Usually, volunteers participating in vaccine trials are not asked to catch the virus, especially if there are many cases like in the current pandemic. This is why trials last for months.